The dilemma of whether to continue TNF&#945; blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ.

Zuzarte, Louise; Mirhadi, Sara; Carr, Richard A; Tso, Simon

The dilemma of whether to continue TNFα blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ.

Zuzarte, Louise; Mirhadi, Sara; Carr, Richard A; Tso, Simon.

Zuzarte L; Jephson Dermatology Center, South Warwickshire NHS Foundation Trust, Warwick, UK.
Mirhadi S; Jephson Dermatology Center, South Warwickshire NHS Foundation Trust, Warwick, UK.
Carr RA; Department of Histopathology, South Warwickshire NHS Foundation Trust, Warwick, UK.
Tso S; Jephson Dermatology Center, South Warwickshire NHS Foundation Trust, Warwick, UK simontso@doctors.org.uk.

BMJ Case Rep ; 12(11)2019 Nov 14.

Article en En | MEDLINE | ID: mdl-31732538

Asunto(s)

Adalimumab/uso terapéutico; Antiinflamatorios/uso terapéutico; Colitis Ulcerosa/tratamiento farmacológico; Melanoma/diagnóstico; Neoplasias Cutáneas/diagnóstico; Factor de Necrosis Tumoral alfa/antagonistas & inhibidores; Anciano; Colitis Ulcerosa/complicaciones; Femenino; Humanos; Melanoma/complicaciones; Melanoma/patología; Factores de Riesgo; Neoplasias Cutáneas/complicaciones; Neoplasias Cutáneas/patología; Melanoma Cutáneo Maligno

Palabras clave

dermatology; immunological products and vaccines; inflammatory bowel disease; pathology

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Colitis Ulcerosa / Factor de Necrosis Tumoral alfa / Adalimumab / Melanoma / Antiinflamatorios Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Aged / Female / Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google